Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
99 participants
OBSERVATIONAL
2019-04-02
2019-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Percentage of gastroenterology fellows who have received any formal training in the ergonomics of endoscopy and how to prevent long term work related injuries.
2.2.2. Secondary Outcome(s)
* How much formal training given in multiple choice format fellows received in the ergonomics of endoscopy and how to prevent work related injuries.
* Number of perceived work related injuries fellows sustained.
* Types of perceived work related injuries fellows sustained.
* If fellow perceived work related injuries whether they felt it negatively affected their ability to perform their duties as a gastroenterology fellow.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It will be distributed to all gastroenterology fellowship coordinators through an email listserv maintained by programs nationwide for the purpose of communicating with their trainees. The email will include instructions to share the survey link (Appendix 2) with all first/second/third year as well as all advanced gastroenterology fellow s in their programs. The survey will be disseminated over a 2 week period. The fellowship coordinator will receive three separate emails. The first email (Appendix 2) will be on opening day of the survey requesting them to forward the link to their fellows. The second email (Appendix 3) will be sent on day 8 of the study period serving as a reminder to participate in the survey with link once again attached. The final email (Appendix 4) will be distributed on day 14 of the study period serving as a final reminder for fellows to complete the survey if they have not already and that the survey will close at midnight. The link will have both the informed consent form and the survey. Participants must press a key indicating agreement to get past the consent to the survey. The survey will take less than 2 minutes to complete electronically. This will be an anonymous survey and will be distributed via a secure online platform.
The results will be compiled using Google Survey© software. No personal identifying information will be included.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First, second and third year as well as advanced gastroenterology fellows
* Able and willing to provide consent
Exclusion Criteria
* Staff gastroenterologists
* Unable or unwilling to provide consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Methodist Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cassandra Craig, M.D.
Role: PRINCIPAL_INVESTIGATOR
The Methodist Hospital Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Methodist Dallas Medical Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
058.GID.2018.D
Identifier Type: -
Identifier Source: org_study_id